Supernus Pharmaceuticals
SUPN
#4425
Rank
C$2.58 B
Marketcap
$46.23
Share price
-0.40%
Change (1 day)
0.13%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2024 (TTM): C$0.13 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings are C$0.66 Billion. , an increase over its 2023 earnings that were of C$7.42 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 C$0.14 B1787.92%
2023 C$7.42 M-92.36%
2022 C$97.08 M-29.8%
2021 C$0.13 B-49.79%
2020 C$0.27 B12.99%
2019 C$0.24 B7.58%
2018 C$0.22 B54.9%
2017 C$0.14 B84.25%
2016 C$79.4 M202.27%
2015 C$26.26 M-462.04%
2014 -C$7.26 Million-94%
2013 -C$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.31 Billion-316.65%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.26 B 1,516.33%๐Ÿ‡บ๐Ÿ‡ธ USA
C$18.15 B 12,856.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$12 Billion-8,661.36%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.04 B 7,065.63%๐Ÿ‡บ๐Ÿ‡ธ USA
C$24.97 B 17,721.60%๐Ÿ‡บ๐Ÿ‡ธ USA